SOX1 antibodies


Suspicion of paraneoplastic syndrome and ambiguous forms of neuropathy.



Accredited analysis for serum samples – read more at the Quality page.


Serum: The result is reported as negative or positive with a value (blot intensity).

CSF: The result is reported as negative or positive


Antibodies against SOX1 (or anti-glial nuclear antibody, AGNA) are unusual but have been reported to occur in paraneoplastic neuropathy, Lambert-Eaton syndrome and in unclear forms of neuropathy and ataxia. SOX1 antibodies are often associated with antibodies against VGCC, Hu, CV2 / CRMP5 or amphiphysin. The most common cancer form associated with SOX1 is small cell lung cancer, but other lung cancer forms have also been reported.

Read more about sampling


Stich et al. Acta Neurol Scand. 2012;125(5):326-31.

Lancaster et al. Neurology. 2011;12;77(2):179-89.

Zuliani et al. J Neurol Neurosurg Psychiatry. 2012;83(6):638-45.

Tschernatsch et al. Autoimmun Rev. 2009 Jun;8(7):549-51.

Packages and other tests

View other packages Lambert-Eatons myastena syndrom (LEMS) (563), Paraneoplastic Syndromes and Limbic Encephalitis (560, 561 and 562). View other tests AMPA receptor 1 and 2 (GluR1 and GluR2) antibodies, Amphiphysin antibodies, CASPR2 antibodies, CV2/CRMP5 antibodies, DPPX (dipeptidyl aminopeptidase-like protein 6) antibodies, GABA B receptor antibodies, GAD antibodies, LGI-1 antibodies, Ma (Ma-2/Ta) antibodies, NMDA receptor antibodies, Purkinje cell antibodies (Tr, Trotter antigen), Recoverin antibodies, Titin antibodies, VGKC (voltage gated potassium channel) antibodies, Yo (PCA-1, Purkinje cells antigen 1) antibodies, Zic4 antibodies

Acute test